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Abstract
Background: Septins are involved in a number of cellular processes including cytokinesis and organization of the
cytoskeleton. Alterations in human septin-9 (SEPT9) levels have been linked to multiple cancers, whereas mutations in SEPT9
cause the episodic neuropathy, hereditary neuralgic amyotrophy (HNA). Despite its important function in human health, the
in vivo role of SEPT9 is unknown.
Methodology/Principal Findings: Here we utilize zebrafish to study the role of SEPT9 in early development. We show that
zebrafish possess two genes, sept9a and sept9b that, like humans, express multiple transcripts. Knockdown or
overexpression of sept9a transcripts results in specific developmental alterations including circulation defects and aberrant
epidermal development.
Conclusions/Significance: Our work demonstrates that sept9 plays an important role in zebrafish development, and
establishes zebrafish as a valuable model organism for the study of SEPT9.
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Introduction
Septin-9 (SEPT9, MSF) is a member of the septin gene family, a
conserved family of filament forming GTPases. To date, at least 14
different septin genes have been identified in humans which, in
addition to cytokinesis, also play roles in vesicle trafficking,
microtubule and actin function, exocytosis, establishment of cell
polarity and cell motility [1,2]. All vertebrate septins have a highly
conserved polybasic domain (PBD) followed by a GTP binding
domain (GBD) homologous to those of the ras-related small
GTPase family of proteins. Outside of the PBD and GBD,
members of the septin family vary greatly in the length and make
up of both the N- and C-termini. SEPT9 is one of three septin
proteins possessing an extended N-terminus containing a proline-
rich region. However, the function of this region is unknown.
The human SEPT9 gene is complex, producing at least seven
mRNA transcripts encoding six distinct polypeptides through
alternative splicing [3]. SEPT9 was initially identified as a fusion
partner of the mixed-lineage leukemia (MLL) gene in acute
myeloid leukemia patients [4]. Altered expression of SEPT9 has
also been implicated in the pathogenesis of a number of cancers,
with evidence for both genetic gain and allelic loss [5,6,7,8]. Point
mutations and intragenic duplications in SEPT9 have also been
linked to hereditary neuralgic amyotrophy (HNA), an autosomal
dominant episodic neuropathy primarily affecting the brachial
plexus [9,10].
In cultured cells, inhibition of SEPT9 isoforms through antibody
microinjection or siRNA transfection results in cytokinesis defects,
including binucleated cells, abnormal daughter cells, cells
remaining attached through a short midbody bridge, and cells
containing condensed DNA suggestive of apoptosis [11,12].
Overexpression of SEPT9 isoforms in cell culture also leads to
an increase in binucleated cells, an accumulation of cells in G2/M
phase and an increase in the percentage of aneuploid cells leading
to suppression of cell growth [13,14]. However, overexpression of
SEPT9 isoforms has also been shown to increase cell motility, and
alter cellular polarity and morphology [14,15].
No mouse knockout has been described, and so the in vivo role of
SEPT9 remains unknown. Moreover, the transcriptional complexity
of the SEPT9 locus will make it very difficult to study the function of
specific isoforms in the mouse. In this study we use the zebrafish
system to investigate the in vivo roleofspecificSEPT9 isoformsin early
development. Zebrafish provide an excellent model for the study of
genes with multipletranscripts since animals growquickly, andcan be
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overexpression constructs and specific transcript inhibition using
morpholino oliogonucleotides (MOs). Zebrafish possess two SEPT9
gene orthologues found on two different chromosomes, sept9a and
sept9b. We found that, similar to humans, these genes express multiple
mRNA transcripts that are expressed throughout development in a
variety of tissues. Inhibition of all Sept9a isoforms or just the largest
Sept9a isoform, sept9a_tv1, led to multiple defects in embryonic
development demonstrating an essential embryonic role for this
isoform. In particular, we observed an increase in apoptosis in the
epidermis of all morphants and alterations in blood circulation.
Overexpression of sept9a_tv1 led to similar developmental defects.
Our results demonstrate the importance of sept9 during embryonic
development.
Materials and Methods
Zebrafish embryos and ethics
Zebrafish were maintained, staged and injected according to
standard procedures [16]. All experiments were approved by and
conducted in accordance with the guidelines established by the
Institutional Animal Care and Use Committee at the University of
Washington, IACUC approval number: 2387-02.
Identification and cloning of sept9 isoforms
BLAST searches using human SEPT9 were used to identify
zebrafish sept9 transcripts. PCR primers were used to amplify
sept9a isoforms from 24 hpf embryos. Primer sequences are
available upon request.
RNA isolation and RT-PCR
RNA was isolated using the RNeasy kit (Qiagen). cDNA was
prepared using Superscript polymerase (Invitrogen) using 1 ug
RNA. sept9 isoforms and ef1a were amplified using transcript
specific primers.
Whole-mount in situ hybridization
Embryos were processed as described [16]. The sept9a_tv1
coding region was used to generate digoxigenin-labeled probes
(Roche).
Morpholino and mRNA injections
Morpholinos targeted to the splice acceptor sites of sept9a_tv1
exons 2 and 5 and sept9a_tv1 mRNA were injected into zebrafish
embryos. The sequences of the morpholinos are: MO2 (59-
TGCGATGCCTGTCAGCACAGAAGAC-39), MO5 (59-CTC-
TGACCTGCACACATGAAGAACA-39), MO2 mismatch (59-
TCCGATCCCTGTGAGCACACAACAC-39), MO5 mismatch
(59-CTGTGAGCTGCAAACATCAACAACA-39). Full-length
sept9a_tv1 was subcloned into the pXLT vector for in vitro
transcription. Messenger mRNA was synthesized using the
mMessage Machine Kit (Ambion).
Acridine orange (AO) staining
For AO staining, embryos were processed as described [17].
Results
Characterization of zebrafish sept9 genes
Through a combination of genetic sequence analysis and
BLAST searches using known human SEPT9 transcripts, we
identified multiple mRNA transcripts produced from two
different zebrafish sept9 genes, sept9a and sept9b. sept9a is located
on chromosome 3, whereas sept9b is found on chromosome 6.
sept9a produces transcripts homologous to the longest human
SEPT9 isoforms 1, 2, and 3, the shortest human variant
SEPT9_v7 (NCBI NM_001113496; named SEPT9_v5i ne a r l i e r
literature [7]) and a unique transcript not identified in other
vertebrates which we have denoted sept9a_tva. Similar to humans,
through the use of alternate 59 exons, sept9a _tv1, 2, 3 and a,
generate predicted protein products with unique N-termini of 32,
18, 7, and 10 amino acids respectively (Fig. 1, and Fig. 2).
sept9a_tv7 encodes a truncated version of the longer transcripts.
sept9b appears to express two human SEPT9_v7 homologues with
alternate 59 UTRs, sept9b_tv1 and sept9b_tv2 (Fig. 1). The
predicted protein sequences of zebrafish sept9a_tv1, 2, and 3 are
73–74% similar and 61–62% identical to their human homo-
logues, respectively (Fig. 2). sept9a_tv7 and sept9b_tv1 and _tv2
primarily encode the GTP binding domain found in all
transcripts, and are highly conserved. These transcripts are
92% similar and 87% identical to each other at the amino acid
level and 87–81% similar, 78–80% identical to the human
sequence. We did not identify transcripts homologous to human
SEPT9 transcript variants 4, 5, and 6 (NCBI NM_001113495,
NM_001113492, and NM_001113494; SEPT9_v5 and v6 known
as v4* and v4 in previous literature [7,15,18]). However, the start
codon in human SEPT9_v5 and v6 is not conserved from
mammals to zebrafish (Fig. 2) and to date, only a single EST of
human SEPT9_v4 has been identified in a teratocarcinoma cell
line, suggesting that these transcripts may not be expressed in
zebrafish. It is possible that further sept9 transcripts are expressed
in zebrafish yet were not identified in this analysis.
Figure 1. SEPT9 transcripts are conserved between zebrafish and mammals. Zebrafish possess two sept9 genes, sept9a and sept9b, that
encode multiple mRNA transcripts homologous to mammalian transcripts. Zebrafish also express a transcript not currently found in mammals,
sept9a_tva. Sites of morpholino splice blockers are noted.
doi:10.1371/journal.pone.0010712.g001
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To examine where sept9 message is expressed in the developing
zebrafish embryo, we performed whole mount in situ hybridization
using a probe to sept9a_tv1. This probe is expected to recognize all
sept9a transcripts, and possibly those of sept9b. Probes designed to
the individual sept9a transcripts were not synthesized because the
unique regions of the longer sept9a isoforms are not large enough
to probe individually. Early maternal expression of sept9 was
ubiquitous (Fig. 3A) and remained so through blastula stages
(Fig. 3B). During gastrulation, sept9 became more restricted to the
axial mesoderm and endoderm (Fig. 3C, D). sept9 was expressed
primarily in the floor plate and ventral mesoderm during
segmentation (Fig. 3E–H). At 24 hours post fertilization, sept9
was expressed in the intermediate cell mass, epidermis, branchial
arches, and pectoral fin bud (Fig. 3I–K).
While we were unable to analyze the spatial expression of
specific sept9 isoforms we could, using RT-PCR, determine the
temporal expression pattern of the various sept9 transcripts.
Zebrafish embryos at different developmental stages were collected
for cDNA preparation and subjected to RT-PCR using transcript
specific primers (Fig. 3L). sept9a_tv2, 3, and a are expressed at the
two cell stage consistent with the maternal sept9a expression
observed in the in situs. Expression of sept9a_tv1, 7 and a, and
sept9b_tv1 commence at high stage, consistent with zygotic
expression, which begins at this time. All five transcripts of sept9a
and both sept9b transcripts stabilize expression though the
segmentation and pharyngula stages. The longest transcript,
sept9a_tv1, has two phases of expression; one during the late
blastula and early gastrula stages, and a second beginning during
early somitogenesis.
Effect of sept9a inhibition on zebrafish development
Because a majority of sept9 transcripts, including the longest
sept9a_tv1, derived from the sept9a locus, we decided to focus
further studies on this set of isoforms. Therefore, we targeted all
sept9a transcripts, or sept9a_tv1 only, for depletion using antisense
morpholinos directed to the splice acceptor site of the fifth (MO5)
or second (MO2) exons of sept9a_tv1, respectively (Fig. 1). Embryos
were injected at the 1-cell stage with 1.25, 2.5 or 5 ng of
morpholino. The observed phenotypes were dosage dependent
Figure 2. SEPT9 amino acid sequence is conserved between zebrafish and mammals. Amino-acid alignments of zebrafish Sept9a and
Sept9b putative protein products show a high degree of conservation. An asterisk notes the starting methionine of human SEPT9_i5/6, which is not
conserved in zebrafish. Arrowheads mark the starting methionines for human Sept9_v7, and zebrafish isoforms Sept9a_tv7 and Sept9b (both
transcripts).
doi:10.1371/journal.pone.0010712.g002
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class II and class III based on morphology (Fig. 4J). At 48 hpf,
embryos that looked similar to wild-type but had epidermal defects
and minor tail perturbations were categorized as class I, those that
had a curved or shortened body axis/tail in addition to the defects
in class I were categorized as class II and those that had a severely
shortened tail/body axis were classified as class III. Both MO5 and
MO2 produced classes I and II (Fig. 4A, B, D, E). However, the
severe class III phenotype (data not shown) was not observed in
MO2 embryos, even at 5 ng of morpholino.
Circulating blood cells could be observed in class I embryos,
however, cells were often observed pooling in the intermediate cell
mass (ICM) and tail region. Classes II and III showed an absence
of blood circulation, and often lacked the presence of mature
hemoglobinized erythrocytes. All classes exhibited yolk extension
as well as epidermal defects, most commonly seen in the tail and
yolk regions. Epidermal aggregates and edema were frequently
noted, often at the tip of the tail and in the ICM. Cardiac edema
was regularly observed in embryos from all classes and worsened
as development proceeded; class II and III embryos did not
survive past 7 days.
The phenotypes resulting from inhibition of septa_tv1 or all sept9a
transcripts were not regularly observed in embryos injected with
mismatch controls to either morpholino (MO2MM and
MO5MM; Fig. 4C, F, J). To determine if sept9a transcript levels
were altered, RT-PCR was performed on 24 hpf MO5 and MO2
embryos injected with 2.5 ng morpholino (Fig. 4K). Levels of
sept9a_tv1 and tv7 were undetectable in MO5 embryos, and
Figure 3. Expression of sept9 genes during zebrafish development. Detection of sept9 mRNA was carried out by whole-mount in situ
hybridization using a probe targeted to all sept9 isoforms on staged embryos from 256 cells to 24 hpf. Images in A–C are lateral views, animal pole to
top; D and E are dorsal views, anterior to top; F and H are dorsal posterior views; G, I and J are lateral views, K is a dorsal view, anterior to left. A–C:
sept9 transcripts are ubiquitously expressed at early developmental states. D: At bud stage, sept9 is expressed in endoderm and axis. E–H: sept9 is
expressed in the floor plate, ventral mesoderm and tail bud during segmentation. I–K: At 24 hpf, sept9 is expressed throughout the epidermis,
branchial arches, pectoral fin, and in the intermediate cell mass. L: Transcript specific primers were used to detect sept9a and sept9b transcripts in
various stages of development by RT-PCR. sept9a_tv 2, 3, and a are expressed maternally. Amplification of eIFa and total RNA without addition of
reverse transcriptase were used as controls. a, axis; ep, epidermis; fp, floorplate; icm, intermediate cell mass; tb, tail bud; vm, ventral mesoderm.
doi:10.1371/journal.pone.0010712.g003
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to wild-type. MO2 also did not affect an amplicon from exons 3–5,
whereas MO5 greatly reduced the level of this product. Since these
exons are shared with sept9a_tv2, 3, and a (Fig. 1), the residual
product may be due to perduring maternal transcripts. Morpho-
linos designed to sept9a_tv1 exon 3 (inhibiting transcript variants 1–
3 and a) and exon 4 (inhibiting all transcripts) acceptor splice sites
(Fig. 1) also produced the same classes of morphants observed in
MO5 embryos (data not shown).
Co-injection of a low concentration (1 pg) of sept9a_tv1 mRNA
with MO2 showed a partial rescue of the morphant phenotypes
providing further evidence that at least classes I and II are a result
of sept9a transcript inhibition (Fig. 4G). The phenotype of MO5
injected embryos could not be rescued by co-injection of sept9a_tv1
mRNA (data not shown). It is possible that sept9a transcripts have
overlapping functions, and that over-expression of only sept9a_tv1
cannot compensate for the loss of multiple transcripts. This also
complicates interpretation of the class III phenotype, as it difficult
to distinguish between a phenotype caused by morpholino artifact
and one caused by knocking-down additional sept9a isoforms that
can not be rescued with sept9a_tv1. However, the observation that
four different sept9a MOs cause similar defects whereas mismatch
Figure 4. Charaterization of sept9a morphant and overexpression embryos. Embryos were injected at the one-cell stage with morpholinos
targeted to all sept9a transcripts (MO5), sept9a_tv1 only (MO2), mismatch controls (MO5MM, MO2MM), or sept9a_tv1 mRNA with and without MO2.
Morphants shown were injected with 2.5 ng morpholino. At 48 hpf, the phenotypes were assessed by morphological criteria, according to severity.
A,D: Class I morphants had defects in epidermal integrity and yolk extension and minor curvature of the tail. B,E: Class II morphants had a curved
body axis in addition to the defects observed in class I. Class III morphants had a severely shortened body axis (data not shown). Arrows indicate yolk
extension defects. All classes exhibited defects in blood circulation. G: Coinjection of 1 pg of sept9a_tv1 mRNA with 5 ng of MO2 partially rescued the
observed phenotypes. H,I: Embryos injected with as little as 4 pg of sept9a_tv1 mRNA often had phenotypes similar to those of sept9a morphants
including epidermal aggregates (arrow), blood pooling, and tail edema (bracket). (OE) indicates over expression. C,F: Control mismatch morpholinos
did not present a phenotype. J: Graphical representation of MO classes at various concentrations. The number of embryos tested in each experiments
is indicated by (n) on top of each column. K: sept9a splice morpholinos inhibit sept9a transcript splicing. RT-PCR analysis was performed on 24 hpf
wild-type embryos, embryos injected with 2.5 ng MO5 or MO2 (pooled classes I and II), or 5 bp mismatch controls. MO5 embryos show a complete
loss of sept9a_tv1 and sept9a_tv7. The presence of a low level of sept9a exons 3–5 transcripts in MO5-injected embryos may be due to maternal
mRNA. MO2 embryos show a decrease in sept9a_tv1 compared to wild-type while the other transcripts are not affected.
doi:10.1371/journal.pone.0010712.g004
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is rescued by co-injection of sept9a_tv1 mRNA, demonstrates that
the observed morphant phenotypes are due to specific loss-of-
function of sept9 and not toxicity.
Effect of sept9a_tv1 overexpression on zebrafish
development
Recent studies in cultured cells have shown that human SEPT9
appears to be highly regulated [12,13,14]. While attempting
rescue of sept9a morphant embryos, we found that increased levels
of sept9a_tv1 mRNA led to a number of embryonic developmental
defects including alterations in convergence and extension,
dorsalization, and cyclopia. However, the phenotypes did not
clearly group into classes like the sept9a morphant embryos.
Interestingly, many of the phenotypes were similar to those
observed in sept9a morphants including cardiac and tail fin edema,
a curved tail and/or body axis, a loss of circulating blood cells with
concentrated pools of cells in the tail region and ICM, and
epidermal defects including regions of aggregated cells (Fig. 4H, I).
Thus, some phenotypes were observed with both gain and loss of
sept9a_tv1 function, whereas other phenotypes were only found in
gain-of-function experiments.
Knock-down and overexpression of sept9a cause an
increase in cell death
Alterations in human SEPT9 have been shown to cause defects
in cytokinesis, leading to changes in cell morphology and decreases
in cellular growth [12,14]. To determine if the defects observed in
the tails of sept9a_tv1 morphant and overexpression (OE) embryos
included an increase in apoptotic cells, we used acridine orange
(AO) to mark cell death. AO-positive cells were rarely observed in
wild-type embryos, yet both sept9a MO2 and sept9a_tv1 OE
embryos showed an increase in apoptotic cells in the tail indicating
cell death (Fig. 5). These data suggest that both loss- and gain-of-
function of sept9a in zebrafish lead to an increase in cell death
possibly through defects in cell division.
Discussion
In this study we have shown that, like humans, zebrafish express
multiple sept9 transcripts. These transcripts are expressed through-
out development in different tissues types including the ventral
mesoderm and axis at early developmental stages, and the
epidermis at later stages. We have demonstrated that inhibition
and overexpression of sept9a transcripts in zebrafish embryos lead
to a myriad of phenotypes including edema, loss of blood
circulation, tail fin malformations, loss of epidermal integrity and
increased cell death. Additionally, we have provided evidence that
multiple sept9a MOs targeted to different splice sites yield similar
phenotypes, and that overexpression of sept9a_tv1 causes develop-
mental defects similar to those observed with the MOs. Thus, too
much or too little sept9a function is deleterious for many embryonic
cells, indicating that cells need to carefully regulate sept9a levels.
The correct levels of sept9a, therefore, are needed to maintain
tissue integrity and to allow normal cell division.
The fact that zebrafish posses two sept9 orthologues (sept9a and
sept9b) is not unusual, given the proposed genomic duplication
event that occurred in teleost fish [19]. The two orthologues
appear to have evolved such that only sept9a expresses longer
isoforms possessing a proline-rich region, while both genes express
shorter isoforms primarily consisting of a GTP-binding domain.
The predicted polypeptides are highly similar to mammalian
SEPT9 proteins, suggesting possible overlapping functions. While
zebrafish do not appear to express homologues to human SEPT9
transcripts 5 and 6, they do express two additional variant 7
transcripts from sept9b. It is possible that these transcripts are
regulated in a manner similar to SEPT9_v5 and v6 [18]. Further
studies are required to determine if sept9a and sept9b have
overlapping functions in zebrafish.
RT-PCR analysis of human tissues has shown that a majority of
SEPT9 transcripts are expressed in almost every tissue type tested
[6,7] and cultured cell lines express different combinations of
SEPT9 proteins depending on the line [11,12,14,20]. However,
whether different SEPT9 polypeptides interact with one another
and the individual function of each transcript remains to be
determined. We found that zebrafish express multiple sept9
transcripts from two different genes, and confirmed the role of
sept9 during zebrafish development. Moreover, we observed the
same spectrum of phenotypes when we eliminated the largest
sept9a isoform, sept9a_tv1, as when we eliminated all sept9a isoforms,
providing the first evidence that the smaller isoforms cannot
compensate for a lack of the largest isoform.
Recently, a number of sept9a transcripts were identified in an
analysis of hematopoietic genes isolated from zebrafish kidney
marrow [21] and expression of sept9b was shown to be increased in
embryos overexpressing etsrp, a transcription factor required for
vasculogenesis and primitive myelopoiesis in zebrafish [22]. This
studies support the hypothesis that sept9 genes play a role in
hematopoiesis. However, the pericardial edema, loss of blood
circulation and tail malformations observed in both sept9a
morphant and OE embryos are also consistent with defects in
osmoregulation observed when epidermal barrier function is lost
[23] or if fish are exposed to toxins that impair homeostasis of the
Figure 5. Knockdown and overexpression (OE) of sept9a_tv1 results in an increase in apoptotic cells in the tail. Embryos at the one-cell
stage were injected with 2.5 ng of MO2 or 4 pg of sept9a_tv1 mRNA and analyzed for acridine orange (AO) staining at 24 hpf. A–C: The tail fin of
wild-type embryos is negative for AO indicating few apoptotic cells. D–I: Both class II MO2 and sept9a_v1 OE embryos show an increase in AO
staining indicating increased cell death.
doi:10.1371/journal.pone.0010712.g005
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future studies examining the roles of various sept9 isoforms in
developmental processes such as hematopoiesis and epidermal
development.
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